Rescinnamine

From Self-sufficiency
Revision as of 20:02, 30 July 2010 by Citation bot 1 (Talk) (Citations: [Pu178]Tweaked: doi. You can use this bot yourself! Report bugs here.)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Rescinnamine
File:Rescinnamine.svg
Systematic (IUPAC) name
methyl (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}yohimban-16-carboxylate
Clinical data
Routes of
administration		 oral
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 24815-24-5
ATC code C02AA01 (WHO)
PubChem CID 32681
DrugBank APRD00112
Synonyms methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate
Chemical data
Formula C35H42N2O9
Molar mass 634.716 g/mol[[Script error: No such module "String".]]
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.

It is an alkaloid obtained from Rauwolfia serpentina[1] and other species of Rauwolfia.

Brand names

Moderil, Cinnasil, Anaprel

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
Sympatholytic (and closely related) antihypertensives (C02)
Sympatholytics
(antagonize α-adrenergic
vasoconstriction)
Central
Adrenergic release inhibitors
Peripheral
Indirect
Rescinnamine • Reserpine
Direct
Non-selective α blocker
Other antagonists
dual (Bosentan) • selective (Ambrisentan, Sitaxentan)


40px This antihypertensive-related article is a stub. You can help ssf by expanding it.
de:Rescinnamin
  1. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Rescinnamine&oldid=28731"